MARKET

HELP

HELP

Cybin Inc
NASDAQ
7.53
+0.16
+2.17%
After Hours: 7.49 -0.04 -0.52% 19:49 01/09 EST
OPEN
7.41
PREV CLOSE
7.37
HIGH
7.79
LOW
7.30
VOLUME
572.22K
TURNOVER
--
52 WEEK HIGH
10.73
52 WEEK LOW
4.810
MARKET CAP
375.70M
P/E (TTM)
-2.3381
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
TipRanks · 2d ago
Cybin Inc. Showcases Breakthrough Serotonergic Drug Pipeline for Depression and Anxiety
Reuters · 4d ago
Weekly Report: what happened at CYBN last week (1229-0102)?
Weekly Report · 5d ago
Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report
Seeking Alpha · 01/02 20:00
Cybin 2026 Outlook: Clinical Milestones And Cash Position Set Stage For Momentum
Seeking Alpha · 01/02 14:01
Cybin Launches US$100 Million At-the-Market Equity Program
TipRanks · 12/31/2025 20:27
Cybin initiates at-the-market equity program of up to $100 million
Seeking Alpha · 12/31/2025 14:48
Cybin, Xpeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga · 12/31/2025 13:26
More
About HELP
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Webull offers Cybin Inc stock information, including NASDAQ: HELP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HELP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HELP stock methods without spending real money on the virtual paper trading platform.